Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 610-615

  Baumhofer, Julie M ^a   Beinhauer, Brigitte G ^a   Wang, Jacob E ^a   Brandmeier, Helge ^a   Geissler, Klaus ^b   Losert, Udo ^c   Philip, Ramila ^d   Aversa, Gregorio ^e   Rogy, Michael A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Division of Hematology   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d RPR Gencell   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anti inflammatory cytokine; Gene therapy; Septic shock

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GALACTOSAMINE; INTERLEUKIN 13; INTERLEUKIN 4; LIPOSOME; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOCOMPETENCE; IMMUNOMODULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

ANIMALS; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; SHOCK, SEPTIC; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031890857     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5     Document Type: Article

References (22)

1. Lauener, R. P. L., Goyert, S. M., Geha, R. S. and Vercelli, D., Interleukin-4 down-regulates the expression of CD14 in normal human monocytes. Eur. J. Immunol. 1990. 20: 2375-2381.
2. Cosentino, G., Soprana, E., Thienes, C. P., Siccardi, A. G., Viale, G. and Vercelli, D., IL-13 down-regulates CD14 expression and TNF-a secretion in normal human monocytes. J. Immunol. 1995. 155: 3145-3151.
3. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S. and Ulevitch, R. J., Structure and function of lipopolysaccharide binding protein. Science 1990. 249: 1429-1431.
4. Minty, R. R., Chalon, P., Derocq, J.-M., Dumont, X., Guillemont, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Milox, B., Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P. and Caput, D., Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993. 362: 248-250.
5. de Waal Malefyt, R., Figdor, C. G., Huijbens, R. G., Mohan-Peterson, S., Benett, B., Culpepper, J., Dang, W., Zurawski, G. and de Vries, J. E., Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 1993. 151: 6370-6381.
6. Rogy, M. A., Auffenberg, T., Espat, N. J., Philip, R., Remick, D., Wollenberg, G. K., Copeland, E. M. and Moldawer, L. L., Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 1995. 181: 2289-2293.
7. Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamow, S. M., Figari, I. S., Pennica, D., Goeddel, D. V., Palladino, M. A. and Smith, D. H., Protection against endotoxic shock by tumor necrosis factor receptor immunoadhesion. Proc. Natl. Acad. Sci. USA 1991. 88: 10535-10539.
8. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronke, M. and Mak, T., Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993. 73: 457-467.
9. Mosmann, T. R., Yokota, T., Kastelein, R., Zurawski, S. M., Arai, N. and Takabe, Y., Species-specificity of T cell stimulating activities of IL-2 and BSF-1 (IL-4): comparison of normal and recombinant, mouse and human IL-2 and BSF-1 (IL-4). J. Immunol. 1987. 138: 1813-1817.
10. Zurawski, S. M., Vega, F. Jr. and Zurawski, G., Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993. 12: 2263-2270.
11. Aversa, G., Punnonen, J., Cocks, B. G., de Waal Malefyt, R., Vega, F. Jr., Zurawski, S. M., Zurawski, G. and de-Vries, J. E., An IL-4 mutant protein inhibits both IL-4 and IL-13 induced human immunoglobulin G4 and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 1993. 178: 2213-2218.
12. Zurawski, S. M., Chomarat, P., Djossou, O., Bidaud, C., McKenzie, A. N., Miossec, P., Banchereau, J. and Zurawski, G., The primary binding subunit of the human IL-4 receptor is also a component of the IL-13 receptor. J. Biol. Chem. 1995. 270: 13869-13878.
13. Rogy, M. A., Oldenburg, H. S., Coyle, S., Trousdale, R., Moldawer, L. L. and Lowry, S. F., Correlation between APACHE III score and immunological parameters in critically ill septic patients with sepsis. Br. J. Surg. 1996. 83: 396-400.
14. Keegan, A. D., Johnston, J. A., Tortolani, P. J., McReynolds, L. J., Kinzer, C., O'Shea, J. J. and Paul, W. E., Similarities and differences in signal transduction by interleukin-4 and interleukin-13: analysis of Janus kinase activation. Proc. Natl. Acad. Sci. USA 1995. 92: 7681 -7685.
15. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, H. J., Fahey, T. J., Zentella, A., Albert, J. D., Shires, G. T. and Cerami, A., Shock and tissue injury induced by recombinant human cachectin. Science 1986. 234: 470-474.
16. Rogy, M. A., Oldenburg, H. S. A., Calvano, S., Montegut, W. J., Stackpole, S., Van Zee, K. J., Marra, M. N., Scott, R. W., Seilhammer, J. J., Moldawer, L. L. and Lowry, S. F., The role of BPI in the treatment of primate bacteremia and septic shock. J. Clin. Immunol. 1994. 14: 120-133.
17. Oldenburg, H. S. A., Pruitt, J. H., Lazarus, D. D., Rogy, M. A., Chizzonite, R., Lowry, S. F. and Moldawer, L. L., Interleukin-1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine 1995. 7: 510-516.
18. Van Zee, K. J., Moldawer, L. L., Oldenburg, H. S. A., Thompson, W. A., Stackpole, S. A., Montegut, W. J., Rogy, M. A. and Moldawer, L. L., Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-lg fusion protein, Ro 45-2081. J. Immunol. 1996. 156: 2221-2230.
19. Fisher, C. J., Opal, S. M., Dhainaut, J.-F., Stephens, S., Zimmermann, J. L., Nightingale, P., Harris, S. J., Schein, R. M. H., Panacek, E. A. and Vincent, J.-L., Influence of an anti-tumor necrosis factor monoclonal on cytokine antibody on cytokine levels in patients with sepsis. Crit. Care Med. 1993. 21: 318-327.
20. Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H. and Benjamin, E., Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein. N. Engl. J. Med. 1996. 334: 1697-1702.
21. Ziegler-Heitbrock, H. W., Frankenberger, M. and Wedel, A., Tolerance to lipopolysaccharide in human blood monocytes. Immunobiology 1995. 193: 217-223.
22. Philip, R., Liggitt, D., Philip, M., Dazin, P. and Debs, R., Efficient transfection of T lymphocytes in adult mice. J. Biol. Chem. 1993. 268: 16087-16090.